Table 1.
Descriptive characteristics of participants of the DLCST at baseline in 2004
| Characteristics |
Respondents |
Intervention |
Control |
p-value |
|---|---|---|---|---|
| N = 4,104 | N = 2,052 | N = 2,052 | ||
| Gender, women, number, (%) |
4,104 |
905 (44.10) |
932 (45.42) |
0.397 |
| Mean age, years |
4,104 |
57.35 |
57.31 |
0.807 |
| Age group (above mean: 57.3 years) (%) |
4,104 |
1,001 (48.78) |
972 (47.37) |
0.365 |
| Civic status, living alone, number, (%) |
4,076 |
586 (28.58) |
587 (28.60) |
0.980 |
| Mean income per year (DKK) |
4,100 |
316,910 |
315,814 |
0.859 |
| SES group, number, (%) |
4,100 |
|
|
|
| Below 250,000 DKK/year |
|
754 (36.74) |
759 (36.99) |
|
| 250–350,000 DKK/year |
|
650 (31.68) |
643 (31.34) |
|
| Above 350,000 DKK/year |
|
648 (31.58) |
650 (31.68) |
0.972 |
| Charlson co-morbidity index at baseline, number, (%) |
4,104 |
|
|
|
| |
|
|
|
|
| 0 |
|
1,717 (83.67) |
1,693 (82.50) |
0.336 |
| 1 |
|
235 (11.45) |
238 (11.60) |
|
| >1 |
|
100 (4.87) |
121 (5.90) |
|
| Prescription of AD or AX medication at least once during the 4 months period before baseline, number, (%) |
4,104 |
269 (13.11) |
277 (13.50) |
0.713 |
| Prescription of AD or AX medication at least once during the 2 years period before baseline, number, (%) | 4,104 | 483 (23,54) | 502 (24,46) | 0.487 |